Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 3
1973 1
1975 1
1976 4
1979 1
1980 5
1981 1
1982 3
1983 5
1984 2
1986 2
1987 2
1988 1
1989 5
1990 2
1991 9
1992 7
1993 6
1994 3
1995 4
1996 3
1997 2
1998 4
1999 6
2000 4
2001 4
2002 5
2003 9
2004 17
2005 10
2006 13
2007 9
2008 7
2009 11
2010 5
2011 23
2012 16
2013 17
2014 21
2015 14
2016 13
2017 17
2018 15
2019 22
2020 17
2021 25
2022 24
2023 29
2024 31
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Richeldi L, et al. N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836310 Free article. Clinical Trial.
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.
Response.
Shkolnik B, Judson MA, Austin A, Hu K, D'souza M, Zumbrunn A, Huggins JT, Yucel R, Chopra A. Shkolnik B, et al. Among authors: huggins jt. Chest. 2020 Oct;158(4):1783-1784. doi: 10.1016/j.chest.2020.06.076. Chest. 2020. PMID: 33036094 No abstract available.
Response.
Lentz RJ, Maldonado F; GRAVITAS authors. Lentz RJ, et al. Chest. 2020 Jul;158(1):424-425. doi: 10.1016/j.chest.2020.02.028. Epub 2020 Jul 2. Chest. 2020. PMID: 32654717 No abstract available.
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
Schulert GS, Yasin S, Carey B, Chalk C, Do T, Schapiro AH, Husami A, Watts A, Brunner HI, Huggins J, Mellins ED, Morgan EM, Ting T, Trapnell BC, Wikenheiser-Brokamp KA, Towe C, Grom AA. Schulert GS, et al. Among authors: huggins j. Arthritis Rheumatol. 2019 Nov;71(11):1943-1954. doi: 10.1002/art.41073. Epub 2019 Oct 1. Arthritis Rheumatol. 2019. PMID: 31379071 Free PMC article.
Pleural manometry.
Huggins JT, Doelken P. Huggins JT, et al. Clin Chest Med. 2006 Jun;27(2):229-40. doi: 10.1016/j.ccm.2005.12.007. Clin Chest Med. 2006. PMID: 16716815 Review.
Intrapleural therapy.
Huggins JT, Doelken P, Sahn SA. Huggins JT, et al. Respirology. 2011 Aug;16(6):891-9. doi: 10.1111/j.1440-1843.2011.02011.x. Respirology. 2011. PMID: 21672085 Review.
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.
Crestani B, Huggins JT, Kaye M, Costabel U, Glaspole I, Ogura T, Song JW, Stansen W, Quaresma M, Stowasser S, Kreuter M. Crestani B, et al. Among authors: huggins jt. Lancet Respir Med. 2019 Jan;7(1):60-68. doi: 10.1016/S2213-2600(18)30339-4. Epub 2018 Sep 14. Lancet Respir Med. 2019. PMID: 30224318 Clinical Trial.
Allergen immunotherapy.
Huggins JL, Looney RJ. Huggins JL, et al. Am Fam Physician. 2004 Aug 15;70(4):689-96. Am Fam Physician. 2004. PMID: 15338781 Free article. Review.
417 results